CTLA4 and neoplasm: In contrast, Murphy et al found no anti‐CTLA4 efficacy in Renca (RCC) engrafted leptin‐induced obese mice, potentially reflecting the differing targets of these ICI classes, or biological differences in the tumour models used [69].